Simple keyword search and advanced search
close
or

NSW Health / 902M - Pharmaceuticals (902M – 1113) Meropenem - HSS-HC-10-902-Meropenem

RFT ID HSS-HC-10-902-Meropenem
RFT Type Pre-Qualified / Invited
Published 15-Dec-2011
Closes 22-Dec-2011 4:00pm
Category Drugs and Pharmaceutical Products
Agency HealthShare NSW


Contact Person
Tim Sweeney
Phone: 02 8644 2257
timothy.sweeney@hss.health.nsw.gov.au

Tender Details

This is a tendering exercise supplementary to 902 – Pharmaceuticals, (which was awarded in 2011, and commenced on 1 August, 2011).

This tender is for formulations and presentations of Meropenem ONLY.

It is ONLY open to suppliers of the current 902 – Pharmaceuticals contract (this restriction being based upon advice HSS-BPS Pharmaceuticals Team currently holds that all properly registered potential suppliers of Meropenem to the NSW market are current suppliers on this contract).

With the foregoing in consideration, the State Contracts Control Board (“the Board”) seeks tenders for Meropenem products.

Tenderers are advised that all successful suppliers must supply under the same terms and conditions as they are currently committed to for 902 – Pharmaceuticals.

Therefore, Tenderers are only required to submit the details as sought in the Excel spreadsheet accompanying these instructions, entitled 902M – Meropenem Response and Pricing Schedule’.

All conditions of the original 902 – Pharmaceuticals contract and RFT apply, with the following variations to be noted:

 

  1. Tender Issue Date:  15 December, 2011

Tender Close Date: 22 December, 2011

Tender Close Time: 4:00 PM EDST (Sydney Time)

NOTE: 7 DAY TENDER PERIOD ONLY

 

  1. Tender Validity Period:

Offers must be valid for consideration three (3) months from the time of submission.

 

  1. Tender Price Variation:

Mechanisms tenderers select for their Meropenem offer must conform to one of those available in the original RFT; however, Tenderers should indicate if they wish to supply Meropenem on a different price variation basis to their other products, and if so, what this basis is.

This can be indicated in the ‘Price Variation’ section of the 902M – Meropenem Response and Pricing Schedule’

 

Contract Period:

Agreement for supply will be effective commencing from award (expected in late January, 2012) through to 31 July, 2013 (with 3 x 12 month extension options), as per the current 902 – Pharmaceuticals contract.

 

If there are any questions regarding this process, please contact:

 

Tim Sweeney - Tendering Officer

T: (02) 8644 2257

F: (02) 8644 2242

E: timothy.sweeney@hss.health.nsw.gov.au

Please Note: As per the original RFT, the Board reserves the right to award or not award as a result of the tender process.

 

Location

NSW Regions: Central West, Far West, Hunter, Illawarra, Mid North Coast, Murray, Murrumbidgee, Northern, North Western, Richmond Tweed, South Eastern, Sydney
States and Territories: ACT

Estimated Value

From $0.00 to $7,200,000.00

RFT Type

Pre-Qualified / Invited - Only those directly invited to tender, may obtain an RFT for the purpose of lodging a tender response. Generally an invitation from a pre-qualified register of approved tenderers who have the ability to undertake the particular work or type of work proposed, a limited number of service providers are known to carry out the work or service (or in emergency or other restricted situations). Tenderers have usually been pre-qualified, accredited, or selected for the type of work and financial range. Competitive bids called from a standing offer (panel / period) contracts would also use this type.

Related Records


Additional Details / Instructions

Refer to C902M Meropenem RFT Instructions.pdf and 902 - Meropenem Response and Pricing Schedule.xlsx

Conditions for Participation

Refer to C902M Meropenem RFT Instructions.pdf and 902 - Meropenem Response and Pricing Schedule.xlsx